Qiagen names Jonathan Pratt as CEO, effective Sept. 1
QGEN•Qiagen appoints new chief executive
Qiagen appointed Jonathan M. Pratt as CEO, effective Sept. 1, 2026.
Pratt most recently ran Filtration Group through its sale to Parker-Hannifin in August 2026.
Shareholder vote planned for Q4 2026
Pratt will be nominated for election as managing director at an extraordinary shareholders’ meeting planned for Q4 2026.
Background on Pratt and transition plan
Earlier roles included senior vice president at Waters’ Waters Division, president of Beckman Coulter Life Sciences, and leadership posts at Pall.
Outgoing CEO Thierry Bernard will step down, remaining through year-end to support the transition.
